Navigation Links
Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
Date:2/12/2013

ALLEGAN, Mich., Feb. 12, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and Chief Financial Officer Judy Brown will present at the Leerink Swann Global Healthcare Conference on Thursday, February 14, at 8:30 AM (EST) in New York City, NY.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, pet health, dietary supplements and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections.  While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 30, 2012, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Company Acquires U.K.-based Rosemont Pharmaceuticals Ltd. For Approximately £180 Million Or $283 Million
2. Perrigo Confirms FDA Approval For Testosterone Gel 1%
3. Perrigo Reports Record Second Quarter Revenue, Adjusted Earnings and Operating Cash Flow
4. Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
5. Perrigo Commences Launch Of Clobetasol Emulsion Propionate Foam, 0.05%
6. Perrigo Company To Release Second Quarter Fiscal Year 2013 Results On February 1, 2013
7. Perrigo Company Announces The Appointment Of Industry Veteran To Executive Vice President And General Manager, Rx
8. Perrigo Announces FDA Final Approval Of Betamethasone Valerate Foam 0.12%
9. Perrigo Company To Present At The Credit Suisse Healthcare Conference
10. Perrigo Reports Record First Quarter Revenue And Adjusted Earnings And Raises Full Year Adjusted EPS Guidance
11. Perrigo Company Announces Appointment Of New Board Of Directors Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2020)... ... 2020 , ... Rigaku Analytical Devices , the market ... professionals about successes and challenges of making changes to their organizations’ pharmaceutical workflows. ... will take place on October 15, 2020 at 10:00am PDT / 1:00pm EDT. ...
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein Velez, ... at the University of Rochester Medical Center, in Upstate New York. She completed ... with clinical faculty from the Harvard and Yale Departments of Dermatology and is ...
(Date:9/1/2020)... ... ... September is National Ovarian Cancer Awareness Month. Ovarian cancer is the 5th deadliest ... reproductive system. The American Cancer Society estimates that in 2020, about 22,000 women ... disease. Throughout the month of September, Women’s Excellence aims to increase understanding of ...
Breaking Medicine Technology:
(Date:8/31/2020)... , ... August 31, 2020 , ... ... support services to dental groups in the United States, today announced the grand ... of Beaumont, CA. , Patients will enjoy convenient hours, a comfortable office, ...
(Date:8/31/2020)... ... 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , At this ... state of panic, experiencing deep anxiety, immense stress, and right now are needing serious relief ... most people on the planet are experiencing a great degree of emotional discomfort, be it ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang ... persons with autism and other developmental disabilities, as well as supporting staff in ... adolescents with autism, school consultation, and staff development. She joined the company in ...
(Date:8/29/2020)... ... ... When professor and author Randy Pausch was diagnosed with pancreatic cancer, he accepted his ... however, he put together a final lecture in Carnegie Hall in which he offered ... and turned it into something that inspired millions of people worldwide. This inclination to ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , Hespiro™ is a ... respiratory conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. It ... gas and scrubs it free of carbon dioxide in a completely closed “rebreather” ...
Breaking Medicine News(10 mins):